-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Treatment-Free Remission: Who, How, and Why?

Program: Education Program
Session: Chronic Myeloid Leukemia: Where Are We in the Current TKI Era?
Hematology Disease Topics & Pathways:
Diseases, Adult, CML, Therapies, Non-Biological, Mechanisms, Study Population, Myeloid Malignancies, pharmacology, molecular interactions, proteomics
Saturday, December 9, 2017, 7:30 AM-9:00 AM
Bldg C, Lvl 1, Hall C1 (Georgia World Congress Center)
Saturday, December 9, 2017, 2:00 PM-3:30 PM
Bldg B, Lvl 3, B312-B314 (Georgia World Congress Center)

Francois-Xavier Mahon, MD, PhD

Bordeaux Segalen University, Bordeaux, France; Cancer Center of Bordeaux, Institut BergoniƩ, INSERM U1218, University of Bordeaux, Bordeaux, France

Disclosures: Mahon: NOVARTIS PHARMA: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; INCYTE: Honoraria; BMS: Consultancy, Honoraria; PFIZER: Consultancy, Honoraria.

Previous Presentation | Next Presentation >>